LULUStrong Buy
Lululemon Athletica
Price (1y)
Fair price check
6 different valuation methods each estimate what LULU should be worth, then we compare to today's price.
- EV/EBITDAUndervaluedthinks it's a bargain — estimates $327.59, about 175% above today
- P/E multiplesUndervaluedthinks it's a bargain — estimates $308.28, about 159% above today
- P/B multiplesUndervaluedthinks it's a bargain — estimates $269.84, about 126% above today
- Residual IncomeFairthinks it's fairly priced — estimates $128.49, about 8% above today
- DCF (2-stage)Fairthinks it's fairly priced — estimates $124.35, about 4% above today
- Graham (defensive)Fairthinks it's fairly priced — estimates $113.96, about 4% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $113.96 |
| P/E multiples(vs sector peers) | $308.28 |
| P/B multiples(vs sector peers) | $269.84 |
| EV/EBITDA(vs sector peers) | $327.59 |
| Residual Income | $128.49 |
| DCF (2-stage) | $124.35 |
- cross source disagreement
Median of all applicable methods (current price $119.14). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency73Strong
- ValuePrice vs fundamentals86Strong
- GrowthRevenue & earnings trajectory81Strong
- MomentumRecent price strength14Poor
- HealthBalance sheet & solvency76Strong
- ProfitabilityROE, ROA, ROIC82Strong
- TechnicalTrend & volatility signals30Weak
- RiskVolatility & drawdown profile6Poor
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $13.16B |
| Revenue (TTM) | $11.10B |
| Net income (TTM) | $1.58B |
| Operating cash flow (TTM) | $1.60B |
| CapEx (TTM) | $680.80M |
| Free cash flow (TTM)CFO − CapEx | $921.67M |
| Total assets | $8.46B |
| Total liabilities | $3.49B |
| Stockholders' equity | $4.96B |
| Cash & equivalents | $881.32M |
| Shares outstanding | 110.48M |
| EPS (basic) | $13.27 |
| EPS (diluted) | $13.26 |
| P/E ratio (TTM) | 8.34 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-03-17
- Latest period end
- 2026-03-11
- Filing lag
- 60 days
- Missing metrics
- 5(research_and_development, interest_expense, dividends_paid, accounts_receivable, long_term_debt)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.